These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

133 related items for PubMed ID: 8696946

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Estradiol stimulates apolipoprotein A-I- but not A-II-containing particle synthesis and secretion by stimulating mRNA transcription rate in Hep G2 cells.
    Jin FY, Kamanna VS, Kashyap ML.
    Arterioscler Thromb Vasc Biol; 1998 Jun; 18(6):999-1006. PubMed ID: 9633943
    [Abstract] [Full Text] [Related]

  • 3. Upregulation of low density lipoprotein receptor by gemfibrozil, a hypolipidemic agent, in human hepatoma cells through stabilization of mRNA transcripts.
    Goto D, Okimoto T, Ono M, Shimotsu H, Abe K, Tsujita Y, Kuwano M.
    Arterioscler Thromb Vasc Biol; 1997 Nov; 17(11):2707-12. PubMed ID: 9409246
    [Abstract] [Full Text] [Related]

  • 4. Niacin, but not gemfibrozil, selectively increases LP-AI, a cardioprotective subfraction of HDL, in patients with low HDL cholesterol.
    Sakai T, Kamanna VS, Kashyap ML.
    Arterioscler Thromb Vasc Biol; 2001 Nov; 21(11):1783-9. PubMed ID: 11701466
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Secretion of prebeta HDL increases with the suppression of cholesteryl ester transfer protein in Hep G2 cells.
    Sawada S, Sugano M, Makino N, Okamoto H, Tsuchida K.
    Atherosclerosis; 1999 Oct; 146(2):291-8. PubMed ID: 10532685
    [Abstract] [Full Text] [Related]

  • 7. Pioglitazone stimulates apolipoprotein A-I production without affecting HDL removal in HepG2 cells: involvement of PPAR-alpha.
    Qin S, Liu T, Kamanna VS, Kashyap ML.
    Arterioscler Thromb Vasc Biol; 2007 Nov; 27(11):2428-34. PubMed ID: 17872455
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Human S mu binding protein-2 binds to the drug response element and transactivates the human apoA-I promoter: role of gemfibrozil.
    Mohan WS, Chen ZQ, Zhang X, Khalili K, Honjo T, Deeley RG, Tam SP.
    J Lipid Res; 1998 Feb; 39(2):255-67. PubMed ID: 9507986
    [Abstract] [Full Text] [Related]

  • 10. Rosuvastatin selectively stimulates apolipoprotein A-I but not apolipoprotein A-II synthesis in Hep G2 cells.
    Qin S, Koga T, Ganji SH, Kamanna VS, Kashyap ML.
    Metabolism; 2008 Jul; 57(7):973-9. PubMed ID: 18555840
    [Abstract] [Full Text] [Related]

  • 11. Protein-DNA interactions at a drug-responsive element of the human apolipoprotein A-I gene.
    Zhang X, Chen ZQ, Wang Z, Mohan W, Tam SP.
    J Biol Chem; 1996 Oct 25; 271(43):27152-60. PubMed ID: 8900208
    [Abstract] [Full Text] [Related]

  • 12. Effect of low density lipoproteins, high density lipoproteins, and cholesterol on apolipoprotein A-I mRNA in Hep G2 cells.
    Monge JC, Hoeg JM, Law SW, Brewer HB.
    FEBS Lett; 1989 Jan 30; 243(2):213-7. PubMed ID: 2492952
    [Abstract] [Full Text] [Related]

  • 13. The effects of short-chain fatty acids on the transcription and secretion of apolipoprotein A-I in human hepatocytes in vitro.
    Tayyeb JZ, Popeijus HE, Mensink RP, Konings MCJM, Mulders KHR, Plat J.
    J Cell Biochem; 2019 Oct 30; 120(10):17219-17227. PubMed ID: 31106471
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Mechanism of action of gemfibrozil on lipoprotein metabolism.
    Saku K, Gartside PS, Hynd BA, Kashyap ML.
    J Clin Invest; 1985 May 30; 75(5):1702-12. PubMed ID: 3923042
    [Abstract] [Full Text] [Related]

  • 16. A novel compound 4010B-30 upregulates apolipoprotein A-I gene expression through activation of PPARγ in HepG2 cells.
    Du Y, Wang L, Si S, Yang Y, Hong B.
    Atherosclerosis; 2015 Apr 30; 239(2):589-98. PubMed ID: 25734982
    [Abstract] [Full Text] [Related]

  • 17. Increased high density lipoprotein (HDL), defective hepatic catabolism of ApoA-I and ApoA-II, and decreased ApoA-I mRNA in ob/ob mice. Possible role of leptin in stimulation of HDL turnover.
    Silver DL, Jiang XC, Tall AR.
    J Biol Chem; 1999 Feb 12; 274(7):4140-6. PubMed ID: 9933608
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Remodeling of HDL containing apoA-I but not apoA-II (LpA-I) by lipoprotein-deficient plasma and hepatic lipase: its effect on the structure and cellular cholesterol-reducing capacity of LpA-I.
    Ohta T, Ikeda Y, Hattori S, Matsuda I.
    Biochim Biophys Acta; 1996 Sep 27; 1303(2):137-44. PubMed ID: 8856043
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.